Investing in the future | Biomedicament announced on February 2, 2022 the eight public-private consortia winners of the call for projects “Grand Défi Biomédicaments: improving yields and controlling production costs”.
MTInov is a partner in the ACCESS, IT’SME and SEQRET projects.
For more information, see the presentation of our projects on the website and visit the government website for the press release (https://www.gouvernement.fr/investir-l-avenir-biomedicament-annonce-des-8-laureats-de-l-appel-a-projets-aap-grand-defi-0)